科华生物：公司生化免疫流水线业务实现了“三线一体”产品矩阵

Core Viewpoint - The company has developed a "three-line integration" product matrix for its biochemical immunoassay production line, catering to various market needs and hospital levels [2] Group 1: Product Offerings - The company offers the mini LAS production line, targeting grassroots inspection departments and capable of serving emergency departments in large hospitals [2] - The LAS Pro biochemical immunoassay production line is designed for secondary hospitals and above [2] - The company provides compatible production line supporting products and services for hospitals with broader online needs, specifically targeting secondary hospitals and above [2] Group 2: Market Strategy - The "three-line integration" approach addresses different application scenarios, allowing for customized and personalized user requirements [2] - The company has already installed its biochemical immunoassay production lines in multiple hospitals [2] - The company plans to leverage its comprehensive sales network and service system to actively expand its market presence in the biochemical immunoassay production line sector [2]